CorMedix (CRMD) EBT Margin (2013 - 2025)

CorMedix (CRMD) reported EBT Margin of 43.89% for Q4 2025, up 75.0% on a YoY basis from 25.08% in Q4 2024, and down 12.96% sequentially from 50.42% in Q3 2025.

CorMedix (CRMD) EBT Margin (2013 - 2025) Analysis & Trends

CorMedix (CRMD) has 12 years of EBT Margin data on file, last reported at 43.89% in Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 75.0% year-over-year to 43.89%; the trailing twelve-month figure through Dec 2025 stood at 48.13% (up 9255.0% YoY), and the FY2025 full-year result was 48.13%, up 9258.0% from the prior year.
  • EBT Margin retreated to 43.89% in Q4 2025, from 50.42% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 52.82% in Q1 2025 to a low of 106896.41% in Q1 2022.
  • A 4-year average of 26855.79% and a median of 13814.54% in 2021 frame the typical range for EBT Margin.
  • Peak annual rise in EBT Margin reached 3328633 bps in 2022, while the deepest fall reached 8734617 bps in 2022.
  • Tracing CRMD's EBT Margin over 4 years: stood at 13814.54% in 2021, then tumbled by 100 bps to 27637.7% in 2022, then jumped by 100 bps to 43.14% in 2024, then rose by 2 bps to 43.89% in 2025.
  • Business Quant data shows CRMD's EBT Margin at 43.89% in Q4 2025, 50.42% in Q3 2025, and 51.21% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn 43.89%

Historic Data

Download Data
DateValue
Dec 31, 2025 43.89%
Sep 30, 2025 50.42%
Jun 30, 2025 51.21%
Mar 31, 2025 52.82%
Dec 31, 2024 43.14%
Sep 30, 2024 -24.24%
Jun 30, 2024 -1,755.51%
Dec 31, 2022 -27,637.70%
Sep 30, 2022 -100,538.67%
Jun 30, 2022 -38,537.88%
Mar 31, 2022 -106,896.41%
Dec 31, 2021 -13,814.54%
Sep 30, 2021 -22,498.86%
Jun 30, 2021 -71,824.21%
Mar 31, 2021 -19,550.24%
Dec 31, 2020 -10,925.34%
Sep 30, 2020 -7,096.05%
Jun 30, 2020 -54,441.52%
Mar 31, 2020 -7,770.02%
Dec 31, 2019 131,526.62%